Clinical Trial Update: An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

View source ↗

Summary

This clinical trial update describes an observational study assessing long-term responses to regorafenib in adults with metastatic colorectal cancer in the Unit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED